Please assess the completion status of the following clinical trial:

Trial Title: Electrocardiogram Clinical Validation Study

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Individuals who are 22 years of age and older~* Able to read, understand, and provide written informed consent~* Willing and able to participate in the study procedures as described in the consent~* Have a wrist circumference that fits within the band~* Able to communicate effectively with and follow instructions from the study staff~* For subjects enrolled into the AF population, subjects must have a known diagnosis of AF and be in AF at the time of screening~Exclusion Criteria:~* Physical disability that precludes safe and adequate testing~* Mental impairment resulting in limited ability to cooperate~* Subjects with a pacemaker or implantable cardioverter-defibrillator (ICD)~* Acute myocardial infarction (MI) within 90 days of screening or other cardiovascular disease that, in the opinion of the Investigator, increases the risk to the subject or renders data uninterpretable~* Acute pulmonary embolism, pulmonary infarction, or deep vein thrombosis within 90 days of screening~* Stroke or transient ischemic attack within 90 days of screening~* Subjects taking rhythm control drugs~* Symptomatic (or active) allergic skin reactions such as eczema, rosacea, impetigo, dermatomyositis or allergic contact dermatitis on both wrists or over electrode attachment sites~* Known sensitivity to medical adhesives, isopropyl alcohol, watch bands, or electrocardiogram (ECG) electrodes including known allergy or sensitivity to fluoroelastomer bands primarily used in wrist worn fitness devices~* A history of abnormal life-threatening rhythms as determined by the investigator~* Significant tremor that prevents subject from being able to hold still~* Pregnant women: Women who are pregnant at the time of study participation~* For subjects enrolled into the sinus rhythm population, they must not have any diagnosis of AF

- Gender: ALL
- Minimum Age: 22 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Atrial fibrillation (AF) (Type: OTHER): Patient with a known history of AF who are in AF at the time of study screening.
- Normal Sinus Rhythm (SR) (Type: OTHER): Patient with no known diagnosis of AF or other arrhythmia

Based on this trial design, predict the completion outcome and termination type (if applicable).